Incyte (INCY) Total Current Liabilities (2010 - 2026)

Incyte (INCY) posted Total Current Liabilities of $1.5 billion for Q1 2026, down 1.68% on a QoQ basis from $1.5 billion in Q4 2025, and down 13.41% year-over-year from $1.7 billion in Q1 2025.

Incyte (INCY) Total Current Liabilities (2010 - 2026) Analysis & Trends

Incyte's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

  • Quarterly Total Current Liabilities fell 13.41% year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (down 13.41% YoY) and the FY2025 annual result came in at $1.5 billion, down 7.72% from the prior year.
  • Total Current Liabilities was $1.5 billion for Q1 2026 at Incyte, down from $1.5 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.7 billion in Q1 2025 and bottomed at $886.2 million in Q1 2022.
  • A 5-year average of $1.3 billion and a median of $1.3 billion in 2025 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 42.04% — and 2026, when it fell 13.41%.
  • Incyte's Total Current Liabilities stood at $1.2 billion in 2022, then climbed by 7.2% to $1.2 billion in 2023, then surged by 32.37% to $1.6 billion in 2024, then decreased by 7.72% to $1.5 billion in 2025, then retreated by 1.68% to $1.5 billion in 2026.
  • Business Quant data shows INCY's Total Current Liabilities at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 56.01 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 66.94 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 13.42 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.81 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 289.60 Mn
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn 1.49 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.49 Bn
Dec 31, 2025 1.52 Bn
Sep 30, 2025 1.34 Bn
Jun 30, 2025 1.28 Bn
Mar 31, 2025 1.72 Bn
Dec 31, 2024 1.64 Bn
Sep 30, 2024 1.50 Bn
Jun 30, 2024 1.34 Bn
Mar 31, 2024 1.40 Bn
Dec 31, 2023 1.24 Bn
Sep 30, 2023 1.12 Bn
Jun 30, 2023 1.12 Bn
Mar 31, 2023 1.01 Bn
Dec 31, 2022 1.16 Bn
Sep 30, 2022 1.01 Bn
Jun 30, 2022 926.67 Mn
Mar 31, 2022 886.16 Mn
Dec 31, 2021 854.31 Mn
Sep 30, 2021 742.71 Mn
Jun 30, 2021 660.32 Mn